SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    US ‘Marijuana’ Entrepreneur Launches CBD Range in UK

    By

    AMERICAN cannabis entrepreneur Ralph Morgan decamped to the UK to launch his new CBD wellness company – Collective Hemp Brands.

    The co-founder of Organa Brands has teamed with leading UK-based doctor Dani Gordon to launch the new range featuring daily CBD supplements, pet care, and skin and sun care products. 

    In a press release Mr Morgan and Dr Gordon said the vision for new Colorado-based business is to engage with consumers on their medical journeys.

    Mr Morgan, Chief Executive Officer of Collective Hemp, said he has ‘traded’ the marijuana industry for cannabinoid therapies because ‘I believe the new movement in healthcare is natural remedies’.

    He continued: “This is the age of natural remedies and the era of CBD. It is my goal to amass wide scale behaviour change and help consumers reconnect with the cannabis plant, its cannabinoid properties, and a more natural wellness regime.”

    Dr Gordon, a partner in the company as well as Collective Hemp’s Chief Medical Officer, is a recognised expert in cannabinoid medicine and CBD wellness. 

    She says she is formulating products based on research and ‘botanical medicine and cannabinoid formulations she has used for years’. 

    “Patients are no longer completely relying on their general practitioners for wellness advice and want a more holistic approach to chronic health symptoms and stress-related issues that western medicine, drug-based approaches are not solving well,” she explained.

    Founded in Denver 2012 Organa Brands has annual sales of $100m and was was recently acquired by SLANG Worldwide. 

    Organa Brands is a supplier of vape pens, edibles and other infused products.

    Peter

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free